Prostate Cancer Market Size is Expected to Increase with a CAGR of 8.1% in the 7MM for the study period of 2017-30 owing to rich Pipeline, Increasing Awareness and Better Treatment Options.A m...
Moderna Therapeutics has announced the positive results of trials of its COVID-19 vaccine, mRNA-1273. The results of interim Phase I clinical trial showed promising outcomes in term...
Novartis signs USD 2.1Billion for Endocyte acquisition Novartis has inked USD 2.1 billion agreement to takeover Endocyte. Endocyte, a biopharmaceutical company, headquartered in Indiana, licensed t...
Rice University researchers tested CRISPR to cure sickle cell, now preparing for upcoming challenges A team of Researchers led by Rice University has recently tested CRISPR to correct the sickle ce...
Samsung and Merck launch Remicade biosim at 35% discount After the first biosimilar of Johnson & Johnson’s big-selling immunology drug Remicade hit the market last year at a modest discount, an...
According to WHO, Chronic Obstructive Pulmonary Disease (COPD) is the third leading cause of death g.....
Well, MDS being one of the rare blood cancers, has been into the limelight of researchers since a de.....
Prostate Cancer is the second most common malignancy in men worldwide, after lung cancer. Most Prost.....
Data and analytics today are playing a major role in the organization’s growth. Stakeho...
Onychomycosis is the most commonly prevalent nail infection in adults. It is a fungal i...
The necessity of a robust Angelman syndrome pipeline is indispensable at the current mo...
Neurological disorders are one of the major causes of death and disability across the g...
As per the American Autoimmune Related Diseases Association (AARDA), nearly 50 million ...
